|
Advanced Accelerator Applications has invested approximately $6 million in Atreus Pharmaceuticals which will be used to expand Atreus’ research in molecular imaging based on Annexin V.
The Radiation Therapy Oncology Group (RTOG) has appointed a new lung cancer committee chair, Jeffrey Bradley, MD, associate professor of radiation oncology at the Washington University School of Medicine in St. Louis.
The first Cesium-131 (Cs-131) implant for the treatment of colorectal cancer was performed by doctors at Weill Cornell Medical Center in New York City on Oct. 10, 2009, and the patient had no evidence of cancer recurrence or any side effects that can be attributed to the Cs-131 seed implant at the last follow-up visit, according to IsoRay.
Written by Michael Bassett
 If the organizers of the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America even considered the idea of putting together a conference that could skim along quietly underneath the radar, those thoughts ended Nov. 17 when the U.S. Preventive Services Task Force released its controversial revised mammography guidelines.
Reassurance from negative CT screening results for lung cancer does not reduce the motivation of current smokers to stop smoking and does not lead former smokers to resume the habit, said a study published in the December issue of Cancer Epidemiology, Biomarkers & Prevention, one of multiple journals published by the American Association for Cancer Research.
Written by Editorial Staff
The use of PET respiratory gating in PET/CT results in lesion volumes closer to those assessed by CT and improved measurements of tracer uptake for lesions in the lungs, according to research published in the December issue of the American Journal of Roentgenology.
Simultaneous use of chemotherapy and high-dose radiotherapy has produced encouraging results in the treatment of limited-stage small-cell lung cancer, according to a phase II study presented Tuesday at the 2009 American Society for Radiation Oncology (ASTRO) meeting in Chicago.
The American Medical Association (AMA) has released a new Category 1 CPT code for use of electromagnetic navigation bronchoscopy (ENB), used in the detection of lung cancer.
A single breath hold of 20 seconds can enable more precise measurements of maximum standardized uptake value, especially in the lower lung field and for small tumors--which may be affected by respiratory motion--according to research published in this month’s Journal of Nuclear Medicine.
The Massachusetts Supreme Judicial Court unanimously ruled Monday that cigarette maker Philip Morris should pay for chest CT scans, in order for smokers to detect the early development of lung cancer.
|
Abbott has entered into an agreement with GlaxoSmithKline (GSK) to develop a molecular diagnostic test intended for use as an aid in selecting patients who may benefit from a skin cancer treatment in development by GSK.
A study and an accompanying editorial published in the January issue of Journal of Nuclear Medicine suggests that essential elements were missing from many oncologic PET reports and these deficiencies may render reports less helpful to referring physicians and also lead to misdiagnoses as well as cause coding and billing errors.
Algeta, a cancer therapeutics company, and the Institute for Energy Technology (IFE), based in Oslo, are collaborating to manufacture and supply Alpharadin for future commercial use and in clinical trials.
The chances of finding lung cancer after one and again, after two years of negative first-round tests were one in 1,000 and three in 1,000, respectively, among high-risk patients who were screened by multidetector CT in three rounds and for whom noncalcified pulmonary nodules were assessed according to volume as well as volume doubling time.
Written by Mike Bassett
CHICAGO--CT screening can significantly reduce lung cancer mortality, according to a paper presented Tuesday at the annual meeting of the Radiological Society of North America (RSNA).
Written by Gina Narcisi
The newly implemented International Staging Classification System for Lung Cancer helps evaluate the prognosis and treatment selection for patients diagnosed with lung cancer, according to a Nov. 20 Web cast presented by the International Association for the Study of Lung Cancer (IASLC), in response to its "Staging Manual in Thoracic Oncology," released in the Seventh Edition of TNM in Lung and Pleural Tumours in August.
Stereotactic radiosurgery is a treatment option for patients with early-stage, non-small cell lung cancer who are not able to undergo surgery, according to a study presented Wednesday at the American College of Chest Physicians' CHEST meeting in San Diego.
PET imaging of non-small cell lung cancer prior to receiving radiation therapy should not be the basis for determining areas that may benefit from higher doses of radiation, according to research presented today by investigators at the 51st American Society for Radiation Oncology (ASTRO) annual meeting in Chicago.
Twenty years of screening for breast and prostate cancer—the most diagnosed cancers for women and men—have not brought the anticipated decline in deaths from these diseases, argue experts in an opinion piece published Wednesday in the Journal of the American Medical Association.
Although breast cancer remains the most common cancer afflicting women in the United States, the death rate associated with it is declining at a rate of about 2 percent a year, according to a report by the American Cancer Society (ACS).
|
RSS 
The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).
During the Health IT Standards Committee meeting on Feb. 24 in Washington, D.C., the Clinical Operations Workgroup sought to gather comments on proposed recommendations on implementation specifications for content exchange, vocabulary and code set standards for the Interim Final Rule of meaningful use.
In 2006, the Center for Devices and Radiological Health (CDRH), a branch of the FDA, began examining the number of medical device reports they received. Over the past two years, the number of submitted reports has increased, sparking a demand for the CDRH to make a move to electronic reporting.
A new hospital breaking ground usually isn’t breaking news. But the vision of patient care at one new facility, tentatively named Palomar Medical Center West (PMC West), is currently illegal under California state law.